期刊文献+

^(99)Tc^m直接标记洛美沙星方法研究

Direct Labeling Method of Lomefloxacin With ^(99)Tc^m
下载PDF
导出
摘要 采用Na99TcmO4对洛美沙星进行了直接标记,并对标记条件进行了优化,确定99Tcm标记洛美沙星的最佳条件,并测定了标记物的体外稳定性和脂水分配系数。结果表明,最佳标记条件为洛美沙星3 mg,SnCl2.2H2O 150μg,pH=6,温度为60℃,标记时间为10 min,所得标记物的标记率>95%,放化纯度可达96.98%;标记物体外稳定性良好,可在0.01 mol/L pH7.4的PBS中室温放置6 h,其放化纯度仍>95%;99Tcm-洛美沙星为脂溶性化合物。以上结果表明,99Tcm直接标记洛美沙星的方法操作简单,标记率较高。标记物不需分离纯化,体外稳定性好。 The purpose of this study was to determine the best conditions in synthesis of ^99Tc^m lomefloxacin. Lomefloxacin was directly labeled by Na^99Tc^mO4 , the effects on labeling yield by lomefloxacin, stannous chloride, pH and temperature were evaluated, the labeling yield, stability, and lipid/water partition coefficient were analyzed. The results showed that the labeling yield was more than 95% and the radiochemical purity of ^99Tc^m lomefloxacin was 96.98% . The optimized synthesis conditions of ^99Tc^m lomefloxacin were containing 3 mg lomefloxacin, 150μg SnCl2·2H2O, pH 6, 10 min and 60℃. ^99Tc^mlomefloxacin has an excellent radiochemical characters.^99Tc^m lomefloxacin was fat-soluble. These results demonstrated that the direct labeling method of ^99Tc^m lomefloxacin was easy and efficient.
出处 《同位素》 CAS 2010年第1期6-9,共4页 Journal of Isotopes
关键词 ^99Tc^m洛美沙星 标记 ^99Tc^m lomefloxacin labelling
  • 相关文献

参考文献6

  • 1de Winter F, Van de Wielec, Dumont F, et al Biodistribution and dosimetry of ^99 T^cm_ ciproflox acin, a promising agent for the diagnosis of bacte rial infection [J]. EurJ Nucl Med, 2001, 28 (5) 570-574.
  • 2de Winter F, Gemmel F, Van Laere K, et al. ^99mTc-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperativespine: experience in 48 patients[J]. Eur J Nucl Med Mol Imaging, 2004, 31(2): 233-239.
  • 3Walker RC, Jones-Jackson LB, Martin W, et al. New imaging tool for the diagnosis of infection [J]. Future Microbilol, 2007, 2(5):527-554.
  • 4Siaens RH, Rennen HJ, goerman OC, et al. Synthesis and comparison of ^99mTc enrofloxacin and ^99mTc-ciprofloxacin[J]. J Nucl Med, 2004, 45 (12): 2 088-2 094.
  • 5Zhang C, Hou GH, Han JK, et al. Radioiodine labeled anti-MIF McAb: a potential agent for inflammation 2007, 2007.
  • 6赵荣,汪静,邓敬兰,王江.^(99m)Tc直接法标记Octreotide及其在甲状腺突眼患者的临床初步应用研究[J].中国临床医学影像杂志,2007,18(8):533-536. 被引量:2

二级参考文献9

  • 1管昌田.生长激素抑素肿瘤受体显像[J].国外医学[核医学放射医学分册],1994,18:24-27.
  • 2Bahn RS,Heufelder AE.Pathogenesis of Graves' ophthalmopathy[J].N Engl J Med,1993,329:1468-1475.
  • 3Kolan H,Li J,Thakur Ml.Sandostatin labeled with ^99mTc:in vitro stability,in vivo validity and comparison with 111In-DTPA-Octreotide[J].Peptide Res,1996,9:144-150.
  • 4Marcocci C,Marino M,Rocchi R.Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy[J].J Endocrinol Invest,2004,27:272-280.
  • 5Pervez S,Mushtaq A,Arif M.Technetium-99m direct radiolabeling of lanreotide:a somatostatin analog[J].Applied Radiation and Isotopes,2001,55(5):647-651.
  • 6Pearson DA,James JL,McBride WJ,et al.Somatostatin receptorbinding peptides labeled with ^99mTc:chemistry and initial biological studies[J].J Med Chem,1996,39:1361-1371.
  • 7Rodes BA.Direct labeling of proteins with Tc-99m[J].Nucl Med Biol,2001,18:667-676.
  • 8Paik CH,Phan L,Hong JJ,et al.The labeling of high affinity sites of antibodies with ^99mTc[J].Int J Nucl Med Biol,1985,12:3-8.
  • 9武鸿文,管昌田,梁正路.^(99)Tc^m直接法标记Octreotide[J].同位素,2000,13(3):152-156. 被引量:6

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部